His laboratory continues to study the complex biology of telomeres, as well as the numerous proteins required for their elongation. In parallel, scientists are exploring the possibility of small molecule inhibitors as viable therapeutic anticancer agents that block telomerase and associated proteins.
14.04.2011. (10:23)
-
-
-
- - promjene spremljene- uredi komentar - obriši komentar - prijavi ovaj komentar kao spam - zabrani komentiranje autoru ovog komentara- učitavam...
Xeloda
His laboratory continues to study the complex biology of telomeres, as well as the numerous proteins required for their elongation. In parallel, scientists are exploring the possibility of small molecule inhibitors as viable therapeutic anticancer agents that block telomerase and associated proteins.
14.04.2011. (10:23) - - - - - promjene spremljene- uredi komentar - obriši komentar - prijavi ovaj komentar kao spam - zabrani komentiranje autoru ovog komentara- učitavam...